Lloyds Engineering Works Ltd announces an acquisition

The exact FY24 contribution cannot be established from the Scheme disclosure retrieved here. The Scheme listing identifies the merger documents but does not state the absorbed subsidiaries’ FY24 revenue, EBITDA, or Lloyds Engineering Works’ FY24 standalone revenue and EBITDA ^[1]. Accordingly, the requested percentages cannot be calculated without inventing inputs.

The calculation required is:

• Revenue contribution: aggregate FY24 revenue of the absorbed subsidiaries ÷ Lloyds Engineering Works standalone FY24 revenue
• EBITDA contribution: aggregate FY24 EBITDA of the absorbed subsidiaries ÷ Lloyds Engineering Works standalone FY24 EBITDA

The available structured financial series starts at FY25, not FY24. As a later-period reference, FY25 consolidated EBITDA margin was 17.9% versus 19.2% standalone, a 1.3 percentage-point lower consolidated margin; in FY26, consolidated EBITDA margin was 18.4% versus 17.9% standalone, a 0.5 percentage-point higher margin ^{[2] [3]}. These figures do not establish the FY24 effect of the proposed consolidation.

Conclusion: the Scheme’s FY24 contribution percentages and whether the merger caused a material margin change are not quantifiable from the disclosed figures available here. The later reported margins suggest no persistent, large dilution at the company level, but that is only an indirect observation—not a Scheme-based FY24 conclusion.

The cited NCLT notice does not quantify any cost synergies or operational efficiencies, and it does not disclose the accounting entries required to determine the post-merger net-worth impact.

• Synergies: The filing identifies the proposed absorption of Lloyds Infrastructure & Construction, Metalfab Hightech and Techno Industries into Lloyds Engineering Works, but the cited notice contains no projected savings, percentage reduction in costs, headcount rationalisation, procurement benefits, facility consolidation, or EBITDA impact. Any benefit from a streamlined corporate structure would therefore be an inference, not a quantified filing disclosure. ^[4]
• Goodwill and reserves: The cited extracts do not state whether goodwill will be created, whether any existing goodwill will be eliminated, or whether a capital reserve, merger reserve, securities premium, or other reserve will be adjusted. They also do not provide a pro forma post-merger net-worth bridge. Accordingly, the net-worth effect cannot be determined from this notice alone.
• What is still required: The decisive disclosures would be in the full Scheme and explanatory statement—particularly the accounting-treatment clause, valuation/share-exchange materials, treatment of inter-company investments and balances, cancellation of investments, and the pro forma balance sheet. The exchange-observation process specifically contemplated disclosures on the merger rationale, revenue impact and valuation, but the news report does not provide the underlying accounting outcome. ^[5]

Analytical implication: The merger’s strategic rationale is visible at the entity-consolidation level, but there is no evidence here for a quantified recurring cost takeout or for a goodwill/capital-reserve adjustment that can be incorporated into post-merger net worth.

The NCLT meetings are not the final step. Based on the merger notice, the Scheme remains subject to: (i) approval by the relevant shareholders and unsecured creditors, (ii) subsequent sanction by the NCLT, and (iii) any other regulatory or governmental approvals, permissions and sanctions contemplated by the Scheme. The notice does not itself list a separate Regional Director approval or specify the Scheme’s effective date. ^[4]

Approvals and filings still relevant

• Shareholder and creditor approval: The voting results and Scrutinizer’s Report must be submitted to the NCLT within 30 days after the respective meetings. ^[4]
• NCLT sanction: Even if the meetings approve the Scheme, the merger remains subject to the subsequent sanction of the Mumbai NCLT. ^[4]
• ROC filing: The Scheme would ordinarily require filing of the NCLT-sanctioned order with the relevant Registrar of Companies. However, the cited meeting notice does not state the filing deadline or expressly identify ROC filing as a separate approval.
• Regional Director: The notice does not name a Regional Director order or approval as an outstanding condition. Any Regional Director observations or representations would therefore need to be checked in the Scheme and the subsequent NCLT proceedings rather than assumed from the meeting notice.
• Stock-exchange and other regulatory clearances: NSE and BSE no-objection/observation letters had reportedly been obtained in May 2026, while CCI approval was reported as having been received on 12 May 2026. These should be treated as prior clearances, not remaining approvals, subject to compliance with their conditions. ^{[5] [6]}

Effective date

The anticipated effective date cannot be established from the cited notice. The notice confirms the meeting and approval process but does not reproduce the Scheme clause defining the “Effective Date.” ^[4]

Accordingly, the legally operative date should not be equated with the 16 October 2026 meeting date. The relevant date would be the date specified in the Scheme—typically tied to completion of the required statutory filings after NCLT sanction—but the exact wording and date require the Scheme document itself.

Conditions precedent

The conditions clearly supported by the notice are:

1. approval by the requisite shareholders and unsecured creditors; 2. submission of voting results and the Scrutinizer’s Report to the NCLT; 3. NCLT sanction; and 4. receipt of other approvals, permissions and sanctions required under the Scheme or applicable law. ^[4]

The supplied material does not establish whether the Scheme contains additional bespoke conditions precedent—such as a specific Regional Director clearance, ROC filing condition, lender consent, or a fixed long-stop date. Those should be confirmed from the Scheme’s “Conditions Precedent,” “Effectiveness,” and “Operative Date” clauses before treating the merger as legally effective.